ConductScience.org, home

Paper3045443

Mechanisms of cellular resistance to cisplatin.

Hospers GA and 2 others. Med Oncol Tumor Pharmacother, 1988. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms of cellular resistance to cisplatin. Papers, record 3045443. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3045443

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of cellular resistance to cisplatin.
PubMed
Journal
Med Oncol Tumor Pharmacother
PubMed
Year
1988
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.63
iCite
Revised in PubMed
2026-10-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hospers GAG A
2Mulder NHN H
3De Vries EGE G

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
Biological Transport
Cell Membrane
Cell Nucleus
Cytoplasm
DNA, Neoplasm
Drug Resistance
Humans
Neoplasms

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16941274Amplification of the metallothionein-I gene in cadmium-resistant mouse cells.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6941274PubMed
26408733Depletion of intracellular polyamines may alter DNA conformation in 9L rat brain tumor cells.Science1983https://conductscience.org/library/papers/6408733PubMed
37387835Inter-species comparisons of carcinogenicity.Br J Cancer1980https://conductscience.org/library/papers/7387835PubMed
43539322Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.Cancer Res1987https://conductscience.org/library/papers/3539322PubMed
53085924Effect of alpha-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminedichloroplatinum (II), and vinblastine sulfate on the growth of P3J cells in vitro.Cancer Res1986https://conductscience.org/library/papers/3085924PubMed
66890712New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].Science1982https://conductscience.org/library/papers/6890712PubMed
73802077cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.Cancer Res1987https://conductscience.org/library/papers/3802077PubMed
83539321Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).Cancer Res1987https://conductscience.org/library/papers/3539321PubMed
96542297Tumours from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum.Acta Pharmacol Toxicol (Copenh)1984https://conductscience.org/library/papers/6542297PubMed
102431772Changes in calcium channel activity in membranes from cis-diammine-dichloroplatinum(II)-resistant and -sensitive L1210 cells.Cancer Res1987https://conductscience.org/library/papers/2431772PubMed
117192601DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.Cancer Res1981https://conductscience.org/library/papers/7192601PubMed
123708576Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II).Cancer Res1986https://conductscience.org/library/papers/3708576PubMed
133802104Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.Cancer Res1987https://conductscience.org/library/papers/3802104PubMed
143741760The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro.Br J Cancer1986https://conductscience.org/library/papers/3741760PubMed
153768295Chemical reactivity of monofunctional platinum-DNA adducts.Biochemistry1986https://conductscience.org/library/papers/3768295PubMed
162870801Covalent binding of 1,2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione.Cancer Res1986https://conductscience.org/library/papers/2870801PubMed
176300219Effect of cisplatin on the plasma membrane phosphatase activities in ascites sarcoma-180 cells: a cytochemical study.J Histochem Cytochem1983https://conductscience.org/library/papers/6300219PubMed
186216456Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation.Nucleic Acids Res1982https://conductscience.org/library/papers/6216456PubMed
194040369Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.Biochem Pharmacol1985https://conductscience.org/library/papers/4040369PubMed
203886121Fundamental studies with cisplatin.Cancer1985https://conductscience.org/library/papers/3886121PubMed

See all 50 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
37110640The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives.Molecules2023https://conductscience.org/library/papers/37110640PubMed
12655051New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12655051PubMed
8422692Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclones.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8422692PubMed
2322989Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2322989PubMed
2005898Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA.Mol Cell Biol1991https://conductscience.org/library/papers/2005898PubMed
1872817Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II).Biochem J1991https://conductscience.org/library/papers/1872817PubMed
1540136Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiation.Biochem J1992https://conductscience.org/library/papers/1540136PubMed
1503895Modulation of cis-diamminedichloroplatinum(II) resistance: a review.Br J Cancer1992https://conductscience.org/library/papers/1503895PubMed
1475197Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.Nucleic Acids Res1992https://conductscience.org/library/papers/1475197PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3045443

GET https://conductscience.org/api/papers/v1/3045443/references?page=2